European Respiratory Review: Exploring the nexus of infection and microbiome dynamics offers new avenues in understanding and treating bronchiectasis. bit.ly/3UtqoUl

European Respiratory Review: The chicken or the egg? The complex interplay between bronchiectasis and nontuberculous mycobacterial pulmonary disease: clinical insights, common susceptibility factors and treatment strategies breaking new ground. bit.ly/3x0Zn2G

A bronchiectasis series in the European Respiratory Review to celebrate the 7th World Bronchiectasis Conference bit.ly/3xk34kh

🔬Researchers are invited to submit their research on targeted #airway #immunity in Lung Disease. Share your insights for better health outcomes by submitting today. Deadline: December 31, 2024. ow.ly/SRWq50SzXTB

ERR: This review discusses how novel pharmaceuticals target lysophosphatidic acid signalling in pulmonary fibrosis and summarises clinical trials of these investigational drugs within select fibrotic lung diseases. bit.ly/4cUcumz

ERR: Micro- and nanoplastics (MNPs) evidently possess the capacity to affect lung tissue in disease and health. However, it remains unclear to what extent this occurs upon exposure to ambient levels of MNPs. bit.ly/3vHQsCA

Comparing innate immune responses to respiratory viral infections in different age groups identifies common central hubs that serve as targets for innovative therapeutic and preventive strategies, despite the apparent differences in underlying mechanisms. bit.ly/3xRmRrn

Pre-order your print copy of the ERS Monograph "COVID-19: An Update" before 18 August and receive a €10 discount ow.ly/P2Pr50SFRrj

Starting P1 for tomorrow babyyyyyy. Unexpected but it feels good. We’ll give our best tomorrow for the last race before holidays 😘

Delighted to kick off this years FASEB Lung Epithelium Meeting with brilliant talks by Rawlins Lab William Zacharias followed by panel led by Master of Ceremonies Darrell Kotton — LungCamp 2024 is off to a great start!

Rory Morty ‘s science is pure 🔥! #LUNGSRC FASEB Lung 2024 (everyone is safe and back in the session—)

An evening of elegant bench to bedside with beautiful patient data from Laurie Eldredge, MD, PhD Laurie Eldridge and Anne Hilgendorff , whose patient follow-up for years sheds new insights on BPD. Elegant in every way!

And that’s a wrap! With gratitude to co-organizers of FASEB Lung 2024 jon kropski , Jichao Chen Cincinnati Children’s Research , Jianwen Que and congrats to Team #LungSRC 2026: Anne Hilgendorff William Zacharias Anny Zhou! This picture of Saahithi Mallapragada ‘s joy at her poster = 1000 words!

Our editorial mentoring scheme is open for applications! If you're an early career clinician, allied health professional or PhD-level scientist and you'd like to learn and work with an incredible team of editors producing ERS journals, apply now. ersnet.org/news-and-featu…

Come and join the ERJ! ERS publications Our early career editor mentoring scheme is now open for applications. A fantastic opportunity for early career clinicians and scientists to experience publishing from the inside Apply now! ERS ersnet.org/news-and-featu…

ERS Clinical Training Fellowships (CTF) support early career healthcare professionals through in-depth training at renowned institutions, fostering knowledge exchange and collaboration between HCPs, institutions and countries. Apply now: ersnet.org/education-and-…

ERR: This systematic review identified several variables that contribute to heterogeneity of outcomes following transbronchial lung biopsy in interstitial lung disease, with modifiable procedural factors impacting both diagnostic yield and complications. bit.ly/3XqldYm

ERR: Adherence to CFTR modulators ranged from 62% to 100%. This broad range may be caused by the different measurement strategies and more specifically by the different CFTR modulators. Larger studies with ETI and with standardised measurements are needed. bit.ly/4cjQ25y

ERR: Using physiologically relevant models of chronic respiratory infections in preclinical research has the potential to improve the predictive value of in vitro data and accelerate the development of novel (and more effective) antimicrobial therapies bit.ly/3VIxNzs

The International Conference 2024 of the ERS begins on Saturday 7 September. What to expect for early-career members (ECMs)? ↪️ Top picks and highlights from the ECM representatives of the fourteen ERS assemblies. ersnet.org/congress-and-e…